Journals / Journal of Nursology / 2023 / Cilt: 26 Sayı: 2

Influenza, Pneumococcus, Tetanus, and Herpes Zoster Vaccination Status of Patients Aged 65 Years and Over with Respiratory and Cardiac Problems

Solunum ve Kardiyak Sorunları Olan 65 Yaş ve Üzeri Hastaların İnfluenza, Pnömokok, Tetanoz, Herpes Zoster Aşılanma Özellikleri

Pages
141–147
Publication Date
2023-06-23
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, it is recommended to monitor patients aged 65 and over with respiratory and cardiac problems in terms of vaccination and organize training programs to increase vaccination rates.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study was conducted to determine the vaccination status and rates among patients aged 65 and over with respiratory and cardiac problems.
📊
Key Findings & Data:Methods: The sample of this descriptive and sectional study consisted of 244 patients aged 65 and over admitted to the chest and cardiology clinic at a state hospital in Turkey between July 2018 and July 2019.
💡
Conclusion & Impact:Therefore, it is recommended to monitor patients aged 65 and over with respiratory and cardiac problems in terms of vaccination and organize training programs to increase vaccination rates.
🔬Design:Survey & Empirical Study
📍Scope:2018 Verileri
⚙️Variables:Yaşlılık · bağışıklama · aşılanma

Abstract

Objective: This study was conducted to determine the vaccination status and rates among patients aged 65 and over with respiratory and cardiac problems. Methods: The sample of this descriptive and sectional study consisted of 244 patients aged 65 and over admitted to the chest and cardiology clinic at a state hospital in Turkey between July 2018 and July 2019. The data were collected using the “Structured Questionnaire Form” prepared to determine the sociodemographic, disease, and vaccination status and rates of the patients. Mean, SD, number, percentage, and chi-square tests were used to evaluate the data. Results: Only 11.1% of patients knew about the vaccines that should be administered to those aged 65 or over. The rates of vaccination at the recommended frequency of the patients who were admitted to the chest outpatient clinics were 26.2% in influenza, 7.4% in pneumococcus, 23.8% in tetanus, and 0.8% in herpes zoster and for those admitted to the cardiology outpatient clinics were 9% in influenza, 3.2% in pneumococcus, 22.9% in tetanus, and 0.8% in herpes zoster. Conclusion: Influenza, pneumococcus, tetanus, and herpes zoster vaccination rates of the patients were very low. Therefore, it is recommended to monitor patients aged 65 and over with respiratory and cardiac problems in terms of vaccination and organize training programs to increase vaccination rates.

Özet

Amaç: Bu araştırma, solunum ve kardiyak sorunları olan 65 yaş ve üzeri hastaların aşı özellikleri ile aşılanma oranlarını belirlemek amacıyla yapıldı. Yöntemler: Tanımlayıcı ve kesitsel tipteki araştırmanın örneklemini Temmuz 2018-Temmuz 2019 tarihleri arasında bir devlet hastanesinin göğüs ve kardiyoloji polikliniğine başvuran 65 yaş ve üzeri toplam 244 hasta oluşturdu. Veriler, hastaların sosyodemografik, hastalık ve aşılanma özellikleri ile aşılanma oranlarını belirlemek amacıyla hazırlanan “Yapılandırılmış Soru Formu” ile toplandı. Verilerin değerlendirilmesinde ortalama, standart sapma, sayı, yüzde ve ki-kare testi kullanıldı. Bulgular: Hastaların sadece %11,1’i 65 yaş ve üzerinde uygulanması gereken aşıları bilmekte idi. Aşılanan hastaların önerilen sıklıkta aşı yaptırma oranları göğüs polikliniklerine başvuranlarda; influenza %26,2, pnömokok %7,4, tetanoz %23,8 ve herpes zoster %0,8’dir. Kardiyoloji polikliniklerine başvuranlarda; influenza %9, pnömokok %3,2, tetanoz %22,9 ve herpes zoster %0,8’dir. Sonuç: Hastaların influenza, pnömokok, tetanoz ve herpes zoster aşılanma oranları oldukça düşüktür. Bu nedenle solunum ve kardiyak sorunları olan 65 yaş ve üzeri hastaların aşılanma açısından izlenmesi ve aşılanma oranlarının arttırılmasına yönelik eğitimlerin düzenlenmesi önerilir.

🔖

Cite This Article

OKUR, E., HİNTİSTAN, S., AKBAL, Y. (2023). Influenza, Pneumococcus, Tetanus, and Herpes Zoster Vaccination Status of Patients Aged 65 Years and Over with Respiratory and Cardiac Problems. Journal of Nursology, Cilt: 26 Sayı: 2, 141–147. https://ajindex.com/articles/945353

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Centers for Disease Control and Prevention. Recommended immunizations for adults: by age; 2020. https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html. Accessed July 31, 2020
  2. Weinberger B. Vaccines for the elderly: current use and future challenges. Immun Ageing. 2018;15(1):3. [CrossRef] 3. Alici DE, Sayiner A, Unal S. Barriers to adult immunization and solutions: personalized approaches. Hum Vaccin Immunother. 2017;13(1):213-215. [CrossRef] 4. Çelik A, Altay H, Azap A, et al. Vaccination of adults with heart failure and chronic heart conditions: expert opinion. Turk Kardiyol Dern Ars. 2018;46(8):723-734. [CrossRef] 5. Infectious Diseases and Clinical Microbiology Speciality Society of Turkey, (EKMUD) [Internet]. Adult Immunization Guide; Vaccination in old age; 2019 [cited 2020 May 13]. Available from: file:///C:/Users/Kodlama7/Downloads/eriskin-bagisiklama-rehberi-v-2-2019.pdf
  3. Lang PO, Aspinall R. Vaccination in the elderly: what can be recommended? Drugs Aging. 2014;31(8):581-599. [CrossRef] 7. Haq K, McElhaney JE. Immunosenescence: influenza vaccination and the elderly. Curr Opin Immunol. 2014;29:38-42. [CrossRef] 8. Trıglav TK, Poljak M. Vaccination indications and limits in the elderly. Acta Dermatovenerol Alp Pannonica Adriat. 2013;22(3):65-70
  4. Polat HH, Oncel S, Turhan O, Akcan A, Eravsar K, Yalcin AN. Influenza vaccination in 65 and over age adults in Antalya/Turkey. Turk J Geriatr. 2012;15(4):371-377
  5. Erdoğdu Hİ, Çatak B. Influenza, pneumococcal and herpes zoster vaccination rates amongst people aged 65 years and older and related factors. Turk J Geriatr. 2018;21(4):498-506. [CrossRef] 11. Ciblak MA, Grip Platformu. Influenza vaccination in Turkey: prevalence of risk groups, current vaccination status, factors influencing vaccine uptake and steps taken to increase vaccination rate. Vaccine. 2013;31(3):518-523. [CrossRef] 12. Bal H, Borekci G. Investigation of adult vaccination status and effecting factors in people 65 years and over registered to a family health center in Mersin city. IMJ. 2016;17(4):121-130
  6. Yigitbas BA, Satici C, Tanriverdi E, Gündüz C. Influenza vaccination frequency and associated factors among elderly population, a descriptive study. Turk J Geriatr. 2018;21(4):490-497
  7. Yuruyen M, Ayan G, Demirdag F, et al. Why is vaccination frequency low in elderly patients? Vaccination in elderly patients. J Clin Anal Med. 2018;9(2):138-142
  8. Akman M, Sarısoy M, Uzuner A. The vaccination status and knowled